PDC-CRO Report issue

For profit Phase 3
Founded: Dubai United Arab Emirates (2011)

Organization Overview

First Clinical Trial
2020
NCT04656613
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

PDC-CRO